Labeler
Bionpharma Inc. NDC Codes
Bionpharma Inc. lists 180 finished drug products in the FDA NDC Directory under NDC labeler code 69452.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Ropinirole, Fluvoxamine maleate, olanzapine, Magnesium Citrate, Allergy Relief, Cimetidine, Prochlorperazine Maleate, Terazosin, divalproex sodium, Dexamethasone, Acetaminophen and Ibuprofen, etravirine, Cetirizine Hydrochloride, Ticagrelor, A Health Itch Relief Gel
- Active ingredients
- Diphenhydramine hydrochloride, Ropinirole hydrochloride, Ibuprofen, Fluvoxamine maleate, Olanzapine, Acetaminophen, Magnesium citrate, Cimetidine, Prochlorperazine maleate, Terazosin hydrochloride, Cetirizine hydrochloride, Dimethicone
- NDC labeler codes
- 69452
- Strengths (from the 100 most recently listed products)
- Ibuprofen 125 mg/1; Acetaminophen 250 mg/1; Magnesium citrate 1.745 g/29.6mL; Diphenhydramine hydrochloride 50 mg/1; Diphenhydramine hydrochloride 25 mg/1; Cetirizine hydrochloride 10 mg/1; Ibuprofen 200 mg/1; Dimethicone 125 mg/1; Diphenhydramine hydrochloride 2 mg/100mL; Fluvoxamine maleate 25 mg/1; Fluvoxamine maleate 100 mg/1; Prochlorperazine maleate 5 mg/1; Prochlorperazine maleate 10 mg/1; Dextromethorphan hydrobromide 15 mg/1; Olanzapine 5 mg/1; Olanzapine 10 mg/1; Olanzapine 15 mg/1; Olanzapine 20 mg/1; Glycopyrrolate 1 mg/5mL; Dimethicone 180 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Capsule, Liquid filled, Solution, Liquid, Tablet, Delayed release, Tablet, Orally disintegrating, Suspension, Gel, Ointment, Syrup, Patch, Cream, Tablet, Extended release
- Routes
- Oral, Topical
- Drug classes (FDA established)
- Histamine-1 Receptor Antagonist, Nonsteroidal Anti-inflammatory Drug, Nonergot Dopamine Agonist, Osmotic Laxative, Calculi Dissolution Agent, Serotonin Reuptake Inhibitor, Atypical Antipsychotic, Histamine-2 Receptor Antagonist, Phenothiazine, Anti-epileptic Agent, Mood Stabilizer, alpha-Adrenergic Blocker, Corticosteroid, Sigma-1 Agonist, Uncompetitive N-methyl-D-aspartate Receptor Antagonist, Anticholinergic, Opioid Agonist, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, P2Y12 Platelet Inhibitor, Antihistamine, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Dihydropyridine Calcium Channel Blocker, Amide Local Anesthetic, Antiarrhythmic, Thyroid Hormone Synthesis Inhibitor, gamma-Aminobutyric Acid A Receptor Agonist, Cholinergic Muscarinic Antagonist, Stimulant Laxative, Bile Acid Sequestrant, alpha-Adrenergic Agonist, Biguanide, alpha-1 Adrenergic Agonist, Copper Absorption Inhibitor, Cholinergic Receptor Agonist, Vitamin B6 Analog, Methylxanthine, Bisphosphonate, Cyclooxygenase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 143 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | 69452-233 | 69452-0233-20 | — |
| Naproxen Sodium | Naproxen sodium 220 mg/1 | Capsule, Liquid filledOral | 69452-179 | 69452-0179-22 | — |
| Ibuprofen, Diphenhydramine HCl | Ibuprofen 200 mg/1; Diphenhydramine hydrochloride 25 mg/1 | Capsule, Liquid filledOral | 69452-205 | 69452-0205-0469452-0205-1169452-0205-15+2 more | — |
| Ibuprofen | Ibuprofen 200 mg/1 | Capsule, Liquid filledOral | 69452-212 | 69452-0212-90 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | 69452-160 | 69452-0160-13 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | 69452-159 | 69452-0159-13 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | 69452-161 | 69452-0161-13 | — |
| Calcitriol | Calcitriol .5 ug/1 | Capsule, Liquid filledOral | 69452-208 | 69452-0208-1369452-0208-20 | — |
| Calcitriol | Calcitriol .25 ug/1 | Capsule, Liquid filledOral | 69452-207 | 69452-0207-1369452-0207-20 | — |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | 69452-132 | 69452-0132-17 | — |
| Dofetilide | Dofetilide .125 mg/1 | CapsuleOral | 69452-131 | 69452-0131-17 | — |
| Dofetilide | Dofetilide .5 mg/1 | CapsuleOral | 69452-133 | 69452-0133-17 | — |
| Tetrabenazine | Tetrabenazine 12.5 mg/1 | TabletOral | 69452-117 | 69452-0117-21 | — |
| Tetrabenazine | Tetrabenazine 25 mg/1 | TabletOral | 69452-118 | 69452-0118-21 | — |
| Nimodipine | Nimodipine 30 mg/1 | Capsule, Liquid filledOral | 69452-209 | 69452-0209-1369452-0209-20 | — |
| Clobazam | Clobazam 2.5 mg/mL | SuspensionOral | 69452-116 | 69452-0116-45 | — |
| Rizatriptan Benzoate | Rizatriptan benzoate 10 mg/1 | Tablet, Orally disintegratingOral | 69452-157 | 69452-0157-73 | — |
| Rizatriptan Benzoate | Rizatriptan benzoate 5 mg/1 | Tablet, Orally disintegratingOral | 69452-156 | 69452-0156-73 | — |
| Omega-3-Acid Ethyl Esteromega-3-acid ethyl esters | Omega-3-acid ethyl esters 900 mg/1 | Capsule, Liquid filledOral | 69452-175 | 69452-0175-1769452-0175-22 | — |
| Ethosuximide | Ethosuximide 250 mg/1 | Capsule, Liquid filledOral | 69452-152 | 69452-0152-20 | — |
| Progesterone | Progesterone 100 mg/1 | CapsuleOral | 69452-148 | 69452-0148-20 | — |
| Progesterone | Progesterone 200 mg/1 | CapsuleOral | 69452-149 | 69452-0149-20 | — |
| Paricalcitol | Paricalcitol 2 ug/1 | CapsuleOral | 69452-146 | 69452-0146-13 | — |
| Paricalcitol | Paricalcitol 1 ug/1 | CapsuleOral | 69452-145 | 69452-0145-13 | — |
| Paricalcitol | Paricalcitol 4 ug/1 | CapsuleOral | 69452-147 | 69452-0147-13 | — |
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | 69452-144 | 69452-0144-2069452-0144-30 | — |
| Amantadine HClamantadine hydrochloride | Amantadine hydrochloride 100 mg/1 | Capsule, Liquid filledOral | 69452-142 | 69452-0142-2069452-0142-30 | — |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | 69452-143 | 69452-0143-2069452-0143-30 | — |
| Valproic Acid | Valproic acid 250 mg/1 | Capsule, Liquid filledOral | 69452-150 | 69452-0150-20 | — |
| Ergocalciferol | Ergocalciferol 1.25 mg/1 | Capsule, Liquid filledOral | 69452-151 | 69452-0151-20 | — |
Bionpharma Inc.: common questions
- What is Bionpharma Inc.'s NDC labeler code?
- 69452. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Bionpharma Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.